Rezolute (RZLT)
(Delayed Data from NSDQ)
$7.70 USD
-0.50 (-6.10%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $8.00 +0.30 (3.90%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Rezolute, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RZLT 7.70 -0.50(-6.10%)
Will RZLT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RZLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RZLT
Rezolute (RZLT) Upgraded to Buy: What Does It Mean for the Stock?
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing
RZLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?
Here's Why 'Trend' Investors Would Love Betting on Rezolute (RZLT)
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
Other News for RZLT
Is RZLT showing upside potential? New 52 Week High shows up after tumbling 6.1%
Rezolute (RZLT) Receives Price Target Boost from Maxim Group | RZLT Stock News
Craig-Hallum Sticks to Their Buy Rating for Rezolute (RZLT)
Rezolute price target raised to $20 from $15 at Maxim
Rezolute price target raised by $5 at Maxim, here's why